• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    21 Stocks Moving in Thursday's Pre-Market Session

    1/20/22 6:27:50 AM ET
    $BABA
    $BBIG
    $BTBT
    $BXRX
    Real Estate
    Real Estate
    Recreational Games/Products/Toys
    Consumer Discretionary
    Get the next $BABA alert in real time by email

    Gainers

    • Baudax Bio, Inc. (NASDAQ:BXRX) shares rose 36.2% to $0.2675 in pre-market trading. Baudax Bio, last month, announced a $4.2 million registered direct offering.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) rose 21.5% to $1.02 in pre-market trading after the company announced it received FDA Orphan Drug designation for its multi-antigen target T cell therapy for pancreatic cancer.
    • IceCure Medical Ltd (NASDAQ:ICCM) rose 14.8% to $2.56 in pre-market trading after dipping more than 10% on Wednesday.
    • Casper Sleep Inc. (NYSE:CSPR) rose 12.9% to $6.47 in pre-market trading after the company announced stockholder approval of a merger agreement.
    • Trip.com Group Limited (NASDAQ:TCOM) shares rose 8.9% to $25.56 in pre-market trading.
    • New Concept Energy, Inc. (NYSE:GBR) rose 8.4% to $2.84 in pre-market trading.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) rose 7.8% to $8.97 in pre-market trading.
    • Bit Digital, Inc. (NASDAQ:BTBT) rose 6.8% to $5.36 in pre-market trading after declining around 9% on Wednesday.
    • Pinduoduo Inc. (NASDAQ:PDD) shares rose 6.8% to $68.75 in pre-market trading. DBS Bank recently upgraded the stock from Hold to Buy and announced a $96 price target.
    • Futu Holdings Limited (NASDAQ:FUTU) shares rose 6.5% to $51.64 in pre-market trading.
    • Molecular Partners AG (NASDAQ:MOLN) rose 6.3% to $29.68 in pre-market trading after gaining over 5% on Wednesday. Molecular Partners recently finalized license agreement with Novartis for Ensovibep for COVID-19.
    • JD.com, Inc. (NASDAQ:JD) rose 6.2% to $76.77 in pre-market trading. China's cyberspace regulator has drafted new guidelines mandating the country's internet behemoths obtain its approval before undertaking any investments or fundraisings, Reuters reported.
    • Alibaba Group Holding Limited (NYSE:BABA) rose 5.9% to $135.30 in pre-market trading. The People’s Bank of China (PBOC) cut key lending rates to support the Chinese economy.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Check out these big penny stock gainers and losers

    Losers

    • Star Equity Holdings, Inc. (NASDAQ:STRR) shares fell 30.1% to $1.16 in pre-market trading after the company reported pricing of $14.25 million underwritten public offering.
    • Valneva SE (NASDAQ:VALN) shares fell 20.7% to $37.66 in pre-market trading. Valneva shares jumped 45% on Wednesday after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva's COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) shares fell 16% to $27.50 in pre-market trading.
    • Global-e Online Ltd. (NASDAQ:GLBE) fell 13.3% to $33.59 in pre-market trading.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 11.3% to $5.43 in pre-market trading after jumping 45% on Wednesday. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.
    • LAIX Inc. (NYSE:LAIX) fell 8.2% to $0.46 in pre-market trading.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 6% to $4.26 in pre-market trading after declining around 13% on Wednesday.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares fell 5.4% to $0.68 in pre-market trading after gaining 4% on Wednesday.
    Get the next $BABA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BABA
    $BBIG
    $BTBT
    $BXRX

    CompanyDatePrice TargetRatingAnalyst
    Futu Holdings Limited
    $FUTU
    2/2/2026$213.39Neutral → Buy
    Goldman
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    Full Truck Alliance Co. Ltd.
    $YMM
    1/12/2026Neutral → Underweight
    Analyst
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$200.00 → $180.00Overweight
    Morgan Stanley
    Global-E Online Ltd.
    $GLBE
    12/11/2025Hold → Sell
    Truist
    PDD Holdings Inc.
    $PDD
    12/9/2025$130.00Buy → Neutral
    Arete
    More analyst ratings

    $BABA
    $BBIG
    $BTBT
    $BXRX
    SEC Filings

    View All

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    2/9/26 4:45:01 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Marker Therapeutics Inc. filed SEC Form 8-K: Shareholder Director Nominations, Financial Statements and Exhibits

    8-K - Marker Therapeutics, Inc. (0001094038) (Filer)

    2/9/26 4:06:45 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Trip.com Group Limited

    6-K - Trip.com Group Ltd (0001269238) (Filer)

    2/9/26 4:01:46 PM ET
    $TCOM
    Real Estate

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Huang Erke exercised 205,000 units of Ordinary Shares at a strike of $1.89, increasing direct ownership by 17% to 1,380,000 units (SEC Form 4)

    4 - Bit Digital, Inc (0001710350) (Issuer)

    1/29/26 4:30:25 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    Chief Executive Officer Tabar Samir exercised 205,000 units of Ordinary Shares at a strike of $1.89, increasing direct ownership by 7% to 3,193,089 units (SEC Form 4)

    4 - Bit Digital, Inc (0001710350) (Issuer)

    1/29/26 4:30:02 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    Chief Executive Officer Eberwein Jeffrey E. was granted 5,703 shares, increasing direct ownership by 0.57% to 1,013,527 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    1/16/26 4:43:05 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Futu Holdings upgraded by Goldman with a new price target

    Goldman upgraded Futu Holdings from Neutral to Buy and set a new price target of $213.39

    2/2/26 6:47:07 AM ET
    $FUTU
    Investment Bankers/Brokers/Service
    Finance

    H.C. Wainwright initiated coverage on Molecular Partners AG with a new price target

    H.C. Wainwright initiated coverage of Molecular Partners AG with a rating of Buy and set a new price target of $13.00

    1/27/26 8:47:34 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alibaba upgraded by Arete with a new price target

    Arete upgraded Alibaba from Neutral to Buy and set a new price target of $190.00

    1/21/26 8:25:13 AM ET
    $BABA
    Real Estate

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chief Executive Officer Eberwein Jeffrey E. sold $39,794 worth of Series A Preferred Stock (4,365 units at $9.12) and bought $81,503 worth of shares (7,268 units at $11.21), increasing direct ownership by 27% to 1,007,824 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/31/25 5:02:24 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. sold $173,974 worth of Series A Preferred Stock (18,635 units at $9.34) and bought $109,212 worth of shares (9,709 units at $11.25), increasing direct ownership by 23% to 1,000,556 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/29/25 7:09:34 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. bought $2,999,991 worth of shares (287,631 units at $10.43) and sold $2,999,994 worth of Series A Preferred Stock (320,855 units at $9.35), increasing direct ownership by 15% to 810,217 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/10/25 4:01:17 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved

    Ronen Tsimerman will continue as CFO until successor is appointed CAESAREA, Israel, Feb. 9, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that after nearly a decade of service with IceCure, Chief Financial Officer Ronen Tsimerman has informed the Company of his decision to leave the Company to pursue new opportunities. The Company has initiated a search for a new Chief Financial Officer and has identified compelling candidates with significant experience commercializing disruptive technolo

    2/9/26 4:30:00 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Trip.com Group Limited to Report Fourth Quarter and Full Year of 2025 Financial Results on February 25, 2026 U.S. Time

    SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Trip.com Group Limited (NASDAQ:TCOM, HKEX: 9961)), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2025 financial results on Wednesday, February 25, 2026, U.S. Time, after the market closes. Trip.com Group's management team will host a conference call at 7:00 PM U.S. Eastern Time on February 25, 2026 (or 8:00 AM on February 26, 2026 in the Hong Kong Time) following the announcement. The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived fo

    2/9/26 5:00:00 AM ET
    $TCOM
    Real Estate

    Bit Digital Inc. Reports Monthly Ethereum Treasury and Staking Metrics for January 2026

    NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:BTBT) ("Bit Digital" or the "Company") today announced its monthly Ethereum ("ETH") treasury and staking metrics for the month of January 2026: Key Highlights for January 2026 As of January 31, 2026, the Company held approximately 155,239.4[1] ETH.Based on a closing ETH price of approximately $2,449, as of January 31, 2026, the market value of the Company's ETH holdings was approximately $380.2 million.The Company's total average ETH acquisition price for all holdings was approximately $3,045 as of January 31, 20

    2/6/26 8:00:00 AM ET
    $BTBT
    $WYFI
    Finance: Consumer Services
    Finance

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Financials

    Live finance-specific insights

    View All

    Trip.com Group Limited to Report Fourth Quarter and Full Year of 2025 Financial Results on February 25, 2026 U.S. Time

    SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Trip.com Group Limited (NASDAQ:TCOM, HKEX: 9961)), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2025 financial results on Wednesday, February 25, 2026, U.S. Time, after the market closes. Trip.com Group's management team will host a conference call at 7:00 PM U.S. Eastern Time on February 25, 2026 (or 8:00 AM on February 26, 2026 in the Hong Kong Time) following the announcement. The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived fo

    2/9/26 5:00:00 AM ET
    $TCOM
    Real Estate

    Global-e to Announce Financial Results for the Fourth Quarter and Full Year 2025 on February 18, 2026

    PETAH-TIKVA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (NASDAQ:GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025, before market open on Wednesday, February 18, 2026. Global-e management will host a conference call to review its financial results and outlook. Date:Wednesday, February 18, 2026Time:8:00 AM ETUnited States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865   Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in the Investor Relations

    2/3/26 8:38:41 AM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

    Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for precise delivery of potent alpha-emitting isotopes to tumorsMP0712 Phase 1/2a study open in U.S. with initial clinical data expected in 2026Molecular Partners to host conference call February 2 at 8AM ET (2PM CET), joined by renowned nuclear medicine expert Prof. Ken Herrmann, M.D. ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company deve

    2/2/26 1:00:00 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Leadership Updates

    Live Leadership Updates

    View All

    IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved

    Ronen Tsimerman will continue as CFO until successor is appointed CAESAREA, Israel, Feb. 9, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that after nearly a decade of service with IceCure, Chief Financial Officer Ronen Tsimerman has informed the Company of his decision to leave the Company to pursue new opportunities. The Company has initiated a search for a new Chief Financial Officer and has identified compelling candidates with significant experience commercializing disruptive technolo

    2/9/26 4:30:00 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Bit Digital Announces Appointment of Amanda Cassatt to Board of Directors

    NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:BTBT) ("Bit Digital" or the "Company"), a publicly traded digital asset platform focused on Ethereum-native treasury and staking strategies, today announced the appointment of Amanda Cassatt, founder and Chief Executive Officer of Serotonin, to its Board of Directors effective January 1, 2026. Cassatt previously served as Chief Marketing Officer at Consensys, the leading Ethereum software company, building the infrastructure, tools, and protocols that power the world's largest decentralized ecosystem, where she

    12/22/25 8:00:00 AM ET
    $BTBT
    $WYFI
    Finance: Consumer Services
    Finance

    Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors

    HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of Kathryn Penkus Corzo, R.Ph., MBA to the Company's Board of Directors, effective November 1, 2025. Ms. Penkus Corzo has vast experience as a biopharma executive, drug developer and independent board director with more than 30 years of global leadership spanning R&D, clinical trials, regulatory approvals, commercialization, and corporate strategy across multiple therapeutic modalities and in

    11/5/25 7:30:00 AM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BABA
    $BBIG
    $BTBT
    $BXRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Full Truck Alliance Co. Ltd.

    SC 13G/A - Full Truck Alliance Co. Ltd. (0001838413) (Subject)

    12/3/24 4:30:33 PM ET
    $YMM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by IceCure Medical Ltd.

    SC 13G/A - IceCure Medical Ltd. (0001584371) (Subject)

    11/14/24 9:38:43 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care